|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 300.00 DKK | +3.34% |
|
+7.91% | -7.76% |
| 05-11 | Hims & Hers quarterly revenue misses on weak US business, lower user spending | RE |
| 05-11 | Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity | RE |
| Capitalization | 1,330B 210B 178B 163B 154B 287B 19,986B 289B 1,930B 754B 9,519B 787B 770B 32,954B | P/E ratio 2026 * |
13.2x | P/E ratio 2027 * | 13.6x |
|---|---|---|---|---|---|
| Enterprise value | 1,446B 228B 193B 177B 168B 312B 21,730B 314B 2,099B 820B 10,349B 855B 837B 35,829B | EV / Sales 2026 * |
4.97x | EV / Sales 2027 * | 4.83x |
| Free-Float |
71.44% | Yield 2026 * |
3.84% | Yield 2027 * | 3.75% |
Last Transcript: Novo Nordisk A/S
Trading Novo Nordisk A/S
| 1 day | +3.34% | ||
| 1 week | +7.91% | ||
| Current month | +10.19% | ||
| 1 month | +24.66% | ||
| 3 months | -4.75% | ||
| 6 months | +1.80% | ||
| Current year | -7.76% |
| 1 week | 282.8 | 312.05 | |
| 1 month | 235.95 | 312.05 | |
| Current year | 224.25 | 409.95 | |
| 1 year | 224.25 | 533.4 | |
| 3 years | 224.25 | 1,033.2 | |
| 5 years | 224.25 | 1,033.2 | |
| 10 years | 109.1 | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 06/08/2025 | |
| Director of Finance/CFO | 55 | 14/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 06/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 22/03/2017 |
| Director/Board Member | 51 | 21/03/2018 | |
| Director/Board Member | 61 | 23/03/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.34% | +7.91% | -32.48% | -47.44% | 203B | ||
| +1.95% | +0.38% | +31.64% | +121.83% | 846B | ||
| +0.05% | -2.54% | +43.58% | +36.98% | 533B | ||
| +0.61% | -1.85% | +9.85% | +38.49% | 356B | ||
| -0.94% | -0.97% | +22.40% | +12.53% | 324B | ||
| +1.18% | -0.07% | +31.86% | +14.23% | 282B | ||
| +0.30% | -1.90% | +25.07% | +23.67% | 278B | ||
| -0.09% | -0.78% | +46.48% | -5.61% | 275B | ||
| -0.64% | -0.07% | +23.97% | +40.78% | 179B | ||
| +1.67% | +1.42% | +37.78% | +70.94% | 163B | ||
| Average | +0.56% | -0.63% | +24.01% | +30.64% | 343.84B | |
| Weighted average by Cap. | +0.32% | -1.12% | +27.15% | +46.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 291B 45.92B 38.93B 35.66B 33.75B 62.78B 4,376B 63.32B 423B 165B 2,084B 172B 169B 7,216B | 299B 47.08B 39.91B 36.56B 34.6B 64.36B 4,486B 64.91B 433B 169B 2,137B 177B 173B 7,397B |
| Net income | 97.23B 15.33B 13B 11.91B 11.27B 20.96B 1,461B 21.14B 141B 55.14B 696B 57.53B 56.32B 2,409B | 95.11B 15B 12.72B 11.65B 11.02B 20.5B 1,429B 20.68B 138B 53.94B 681B 56.27B 55.09B 2,357B |
| Net Debt | 116B 18.29B 15.51B 14.21B 13.44B 25.01B 1,744B 25.23B 168B 65.79B 830B 68.64B 67.2B 2,875B | 113B 17.79B 15.08B 13.81B 13.07B 24.32B 1,695B 24.53B 164B 63.97B 807B 66.74B 65.34B 2,795B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/05/26 | 300.00 kr | +3.34% | 7,278,350 |
| 08/05/26 | 290.30 kr | -1.76% | 4,614,317 |
| 07/05/26 | 295.50 kr | +0.85% | 5,530,016 |
| 06/05/26 | 293.00 kr | +2.48% | 15,205,850 |
| 05/05/26 | 285.90 kr | +1.04% | 6,780,981 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition



















